SCHATZBERG AF, NEMEROFF CB: Textbook of Psychopharmacology American Psychiatric Press, Washington DC, USA (1998).
CLARK D, 1985, II. theoretical considerations. Neural Transm., 62, 171, 10.1007/BF01252236
SACHAR EJ, 1975, Arch. Gen. Psychiatry, 32, 885, 10.1001/archpsyc.1975.01760250077008
MELTZER HY, 1975, Biel Psychiatry, 10, 53
10.1001/archpsyc.1976.01770030003001
GRUEN PH, 1978, Arch. Gen. Psychiatry, 35, 108, 10.1001/archpsyc.1978.01770250110011
LYKOURAS L, 2000, Eric Psychiatry, 15, 480, 10.1016/S0924-9338(00)00516-2
COHEN-MANSFIELD J, 2000, Thec Drug Monit., 22, 688, 10.1097/00007691-200012000-00007
CHOU J C-Y, DOUYON R, CZOBOR P, VOLAVKA J, COOPER, 1998, Psychiatry Res., 81, 51, 10.1016/S0165-1781(98)00085-7
KOLAKOWKSA T, 1981, Plasma prolactin response to haloperidol challenge. Br. J. Psychiatry, 139, 400
BLOOM FE, KUPFER DJ: Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, USA (1995).
SCHMIDT AW, 1998, Soc. Nerosci. Abs., 24, 2177
10.1176/appi.ajp.159.1.133
10.1046/j.0306-5251.2001.01448.x
BREIER AF, 1999, Am. J. Psychiatry, 156, 294, 10.1176/ajp.156.2.294
WUDARSKY M, 1999, Child Adelesc. Psychepharmacel, 9, 239, 10.1089/cap.1999.9.239
MELTZER HY, 1989, Psychopharmacol (Berlin), 99, S18–S27, 10.1007/BF00634462
CARACCI G, 1999, Clin. Psychopharmacol, 19, 194, 10.1097/00004714-199904000-00025
MARKIANOS M, 1999, Psychiatry Res., 89, 115, 10.1016/S0165-1781(99)00098-0
DAVID SR, 2000, Clin. The], 22, 1085, 10.1016/S0149-2918(00)80086-7
KEARNS AE, 2000, Endoc. Pract., 6, 425, 10.4158/EP.6.6.425
DANIELS GH, 2001, Ender.. Pract., 7, 224, 10.4158/EP.7.3.224
KLEINBERG DL, 1999, Psychopharmacol, 19, 57, 10.1097/00004714-199902000-00011
CRAWFORD AMK, BEASLEY CM JR, TOLLEFSON GD, 1997, Schizophrenia Res., 26, 41, 10.1016/S0920-9964(97)00036-4
BEASLEY CM JR, TOLLEFSON G, TRAN P, SATTERLEE W, SANGER T, HAMILTON S,, 1996, Neuropsychopharmacol, 14, 111, 10.1016/0893-133X(95)00069-P
10.1001/archpsyc.57.6.553
HAMNER MB, 1996, Psychopharmacol Bull, 32, 107
10.1016/S0006-3223(97)00190-X
SMALL JG, 1997, Arch. Gen. Psychiatry, 54, 549, 10.1001/archpsyc.1997.01830180067009
KING DJ LINK CGG, 1998, Psychopharmacol, 137, 139, 10.1007/s002130050603
10.1097/00004714-199604000-00008
10.1097/00004714-199808000-00009
VERBEECK WJ, 2001, Eur. Neuropsychopharmacol, 11, 215, 10.1016/S0924-977X(01)00086-4
KONDO T, 2000, YASUI N, et al.: Therapeutic spectrum of nemonapride and its relationship with plasma concentrations of the drug and prolactin. j Clin. Psychopharmacol, 20, 404
MELKERSSON KI, 2001, Br. J. Clin. Pharmacol, 51, 317, 10.1046/j.1365-2125.2001.01352.x
BAPTISTA T, 2001, J. Psychiatry, 46, 834
HADAD PM, 2001, J. Psychopharmacol, 4, 293, 10.1177/026988110101500408
